BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 30124506)

  • 1. CyclinD1 Is Useful to Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells.
    Chatterjee D; Vishwajeet V; Saikia UN; Radotra B; De D; Bansal D
    Am J Dermatopathol; 2019 Mar; 41(3):188-192. PubMed ID: 30124506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1 Is Expressed in Neoplastic Cells of Langerhans Cell Histiocytosis but Not Reactive Langerhans Cell Proliferations.
    Shanmugam V; Craig JW; Hornick JL; Morgan EA; Pinkus GS; Pozdnyakova O
    Am J Surg Pathol; 2017 Oct; 41(10):1390-1396. PubMed ID: 28622183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclin D1: potential utility as marker for Langerhans cell histiocytosis.
    Ben Rejeb S; Charfi L; Sahraoui G; Boujelben N; Mrad K; Doghri R
    J Immunoassay Immunochem; 2021 Jul; 42(4):370-379. PubMed ID: 33444078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 Is a Helpful Marker in Distinguishing Langerhans Cell Histiocytosis From Langerhans Cell Hyperplasia.
    Grace SA; Sutton AM; Armbrecht ES; Vidal CI; Rosman IS; Hurley MY
    Am J Dermatopathol; 2017 Oct; 39(10):726-730. PubMed ID: 27759703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine Needle Aspiration of Langerhans Cell Histiocytosis: A Cytopathologic Study of 37 Cases.
    Hang JF; Siddiqui MT; Ali SZ
    Acta Cytol; 2017; 61(2):96-102. PubMed ID: 28407623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
    Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
    Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of the JL1 epitope, which encompasses the nonglycosylation site of CD43, as a marker of immature/neoplastic Langerhans cells.
    Park HJ; Jeon YK; Lee AH; Oh YH; Park SH; Jung KC
    Am J Surg Pathol; 2012 Aug; 36(8):1150-7. PubMed ID: 22790855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Langerhans' cell histiocytosis cells are activated Langerhans' cells.
    Emile JF; Fraitag S; Leborgne M; de Prost Y; Brousse N
    J Pathol; 1994 Oct; 174(2):71-6. PubMed ID: 7965409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression analysis of dendritic/Langerhans cells and Langerhans cell histiocytosis.
    Rust R; Kluiver J; Visser L; Harms G; Blokzijl T; Kamps W; Poppema S; van den Berg A
    J Pathol; 2006 Aug; 209(4):474-83. PubMed ID: 16718746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of clonal lymphoid receptor gene rearrangements in langerhans cell histiocytosis.
    Chen W; Wang J; Wang E; Lu Y; Lau SK; Weiss LM; Huang Q
    Am J Surg Pathol; 2010 Jul; 34(7):1049-57. PubMed ID: 20551822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prominent Langerhans' cell migration in the arthropod bite reactions simulating Langerhans' cell histiocytosis.
    Kim SH; Kim DH; Lee KG
    J Cutan Pathol; 2007 Dec; 34(12):899-902. PubMed ID: 18001411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of cellular adhesion molecules in Langerhans cell histiocytosis and normal Langerhans cells.
    de Graaf JH; Tamminga RY; Kamps WA; Timens W
    Am J Pathol; 1995 Oct; 147(4):1161-71. PubMed ID: 7573361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Langerhans cell histiocytosis: a clinicopathologic and immunohistochemical analysis of 258 cases].
    Xu X; Liu WP; Yang QP; Wang WY; Liao DY; Zhao S; Bi CF; Lin L; Min M
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):91-6. PubMed ID: 22455884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerhans' cell histiocytosis (histiocytosis X): immunophenotype and growth fraction.
    Hage C; Willman CL; Favara BE; Isaacson PG
    Hum Pathol; 1993 Aug; 24(8):840-5. PubMed ID: 7690735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Langerin (CD207) staining in normal pediatric tissues, reactive lymph nodes, and childhood histiocytic disorders.
    Chikwava K; Jaffe R
    Pediatr Dev Pathol; 2004; 7(6):607-14. PubMed ID: 15630529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry.
    Murakami I; Oka T; Kuwamoto S; Kato M; Hayashi K; Gogusev J; Imamura T; Morimoto A; Imashuku S; Yoshino T
    Virchows Arch; 2011 Aug; 459(2):227-34. PubMed ID: 21604205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lesions resembling Langerhans cell histiocytosis in association with other lymphoproliferative disorders: a reactive or neoplastic phenomenon?
    Christie LJ; Evans AT; Bray SE; Smith ME; Kernohan NM; Levison DA; Goodlad JR
    Hum Pathol; 2006 Jan; 37(1):32-9. PubMed ID: 16360413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histologic patterns of thymic involvement in Langerhans cell proliferations: a clinicopathologic study and review of the literature.
    Picarsic J; Egeler RM; Chikwava K; Patterson K; Jaffe R
    Pediatr Dev Pathol; 2015; 18(2):127-38. PubMed ID: 25629953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis of Langerhans cell histiocytosis.
    Badalian-Very G; Vergilio JA; Fleming M; Rollins BJ
    Annu Rev Pathol; 2013 Jan; 8():1-20. PubMed ID: 22906202
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytological Diagnostic Approach in 3 Cases of Langerhans Cell Histiocytosis Presenting Primarily as a Thyroid Mass.
    Oza N; Sanghvi K; Menon S; Pant V; Patil M; Kane S
    Acta Cytol; 2015; 59(5):418-24. PubMed ID: 26496501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.